aTyr Pharma | LIFE - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Alterity Therapeutics Limited AUD 36.21M 18.58M 2025-12
Ardelyx USD 148.62M 18.33M 2026-03
aTyr Pharma USD 57.93M 82.05M 2026-03
Biogen USD 18.65B 394.9M 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Cipla INR 344.32B 15.13B 2026-03
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 95.35M 7.38M 2026-03
CSL USD 18.66B 2.75B 2025-12
Curis USD 5.46M 19.45M 2025-12
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Grifols EUR 6.21B 133.12M 2025-12
Lakefront Biotherapeutics EUR 3.25B 17.5M 2026-03
Novartis USD 38.93B 7.2B 2026-03
Roche Holding CHF 33.8B 758M 2025-12
United Therapeutics USD 5.9B 1.2B 2026-03
Xoma USD 87.94M 15.5M 2025-09